Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>FL *** > Treatment > Co: USA. G. RituxiMAb+Hyaluronidase
Co: USA. G. RituxiMAb+Hyaluronidase's subsections
(*) USA Approval Date: 2017. 06.22
Company
Hyaluronidase Licensor
TradeMark (Hyaluronidase)
TradeMark (RituxiMAb+Hyaluronidase)
Web-Site
Co: USA. G. RituxiMAb+Hyaluronidase's products
This section has no products